Page last updated: 2024-10-23

bepridil and Benign Neoplasms

bepridil has been researched along with Benign Neoplasms in 3 studies

Bepridil: A long-acting calcium-blocking agent with significant anti-anginal activity. The drug produces significant coronary vasodilation and modest peripheral effects. It has antihypertensive and selective anti-arrhythmia activities and acts as a calmodulin antagonist.
bepridil : A tertiary amine in which the substituents on nitrogen are benzyl, phenyl and 3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl.

Research Excerpts

ExcerptRelevanceReference
"The presence of the NCX antigen in the cancer cells was proved by Western blotting, flow cytometry and confocal laser scanning microscopy."1.34Na+/Ca2+ exchanger inhibitors modify the accumulation of tumor-diagnostic PET tracers in cancer cells. ( Balkay, L; Friedlander, E; Krasznai, Z; Márián, T; Németh, E; Szabó, A; Szabó-Péli, J; Trón, L; Veress, G, 2007)
"Bepridil was administered in a continuous 36 h infusion at 22 mg/kg/36 h, with a dose scheme which should result in a steady state plasma concentration of approximately 5 mumol/l, able to reverse anthracycline resistance in vitro."1.28Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients. ( Blokhuis, WM; de Jong, J; Giaccone, G; Maessen, PA; Pinedo, HM; Schuurhuis, GJ; van der Hoeven, JJ; van der Vijgh, WJ; van Kalken, CK, 1991)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamandis, P1
Wildenhain, J1
Clarke, ID1
Sacher, AG1
Graham, J1
Bellows, DS1
Ling, EK1
Ward, RJ1
Jamieson, LG1
Tyers, M1
Dirks, PB1
Márián, T1
Szabó-Péli, J1
Németh, E1
Trón, L1
Friedlander, E1
Szabó, A1
Balkay, L1
Veress, G1
Krasznai, Z1
van Kalken, CK1
van der Hoeven, JJ1
de Jong, J1
Giaccone, G1
Schuurhuis, GJ1
Maessen, PA1
Blokhuis, WM1
van der Vijgh, WJ1
Pinedo, HM1

Other Studies

3 other studies available for bepridil and Benign Neoplasms

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic

2007
Na+/Ca2+ exchanger inhibitors modify the accumulation of tumor-diagnostic PET tracers in cancer cells.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2007, Volume: 30, Issue:1

    Topics: Bepridil; Calcium; Carbon Radioisotopes; Cell Line, Tumor; Choline; Flow Cytometry; Fluorodeoxygluco

2007
Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:6

    Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bepridil;

1991